Rendu Biotech disclosed in the first quarter report on April 30, 2024 that the number of shareholders of the company as of March 31, 2024 was 4,063, a decrease of 261 or 6.04% from the previous period (December 31, 2023).
The number of shareholders of Rendu Biotech is lower than the industry average. According to Choice data, as of March 31, 2024, the average number of shareholders of listed companies in the pharmaceutical and biotechnology industry is 33,900. Among them, the number of shareholders of the company is in the range of 5,000~15,000, accounting for the highest proportion, 28.84%.
Distribution of the number of shareholders in the pharmaceutical and biological industry
Number of shareholders and share price
Since March 31, 2023, the number of shareholders of the company has increased, with an increase of 1.12%. From March 31, 2023 to March 31, 2024, the stock price decreased by 37.08%.
Number of shareholders and share price
Number of shareholders and share capital
As of March 31, 2024, the company's latest total share capital is 40 million shares, of which the outstanding share capital is 30,257,600 shares. The average number of outstanding shares held by households increased from 6,882 shares in the previous period to 7,447 shares, and the average market value of households was 244,300 yuan.
The average amount of shares held by each household
The average circulating market value of Rendu Bio households is lower than the industry average. According to Choice data, as of March 31, 2024, the average market value of A-share listed companies in the pharmaceutical and biological industry is 399,500 yuan. Among them, 25.31% of the company's households hold a circulating stock market value in the range of 130,000~250,000, and Rendu Biotech is also in the range.
Distribution of per capita circulating market value of the pharmaceutical and biological industry
Disclaimer: This article is based on big data and is for reference only and does not constitute any investment advice.